Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
11.16
+0.16 (1.45%)
Nov 20, 2024, 4:00 PM EST - Market closed
Cybin Market Cap
Cybin has a market cap or net worth of $227.14 million as of November 21, 2024. Its market cap has decreased by -19.58% in one year.
Market Cap
227.14M
Enterprise Value
113.01M
1-Year Change
-19.58%
Ranking
Category
Stock Price
$11.16
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $227.14M, an increase of 149.34%. That is a compound annual growth rate of 25.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 227.14M | -8.82% |
| Dec 29, 2023 | 249.11M | 26.60% |
| Dec 30, 2022 | 196.77M | -69.81% |
| Dec 31, 2021 | 651.89M | 233.21% |
| Dec 31, 2020 | 195.64M | 114.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inogen | 239.38M |
| Eledon Pharmaceuticals | 238.96M |
| Sutro Biopharma | 238.31M |
| LifeMD | 237.57M |
| Biomea Fusion | 236.64M |
| Lifecore Biomedical | 235.69M |
| TScan Therapeutics | 235.36M |
| SOPHiA GENETICS | 234.53M |